Investing

Noble Mineral Closes its Non-Brokered Private Placement and Extends Warrants

November 21, 2025
Investing

Joe Cavatoni: Gold’s Key Driver Now, Plus 2026 Catalysts to Watch

November 21, 2025
Investing

Skyharbour Engages Emerging Markets Consulting LLC for Marketing Contract

November 21, 2025
Investing

Heliostar Presents Third Quarter 2025 Financial Results

November 21, 2025
Investing

Crypto Market Update: Bitcoin Price Slide Continues, Kraken Files for IPO

November 21, 2025
Politics

Schumer, Jeffries accuse Trump of calling for ‘execution of elected officials’

November 21, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Cardiol Therapeutics Secures US$11 Million Financing and Extends...

October 18, 2025

Variation to Noteholder Agreements

May 22, 2025

SAGA Metals Completes Strategic Infrastructure Upgrades in Preparation...

July 31, 2025

Sankamap Updates Status on Late Filing of Financial...

November 5, 2025

RCM to Acquire Webbs Consol Silver Project from...

September 1, 2025

Jp Cortez: Is America’s Gold Really There? US...

June 17, 2025

American Uranium LimitedLo Herma Resource Expansion Drilling Approved

September 26, 2025

Successful A$4.5m Two Tranche Placement

October 13, 2025

China Eases Rare Earths Grip, Grants US, EU...

June 10, 2025

John Feneck: Gold Backdrop Looks “Amazing,” Plus 7...

April 22, 2025